secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001193125-24-255170
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Werewolf Therapeutics posts updated corporate presentation with no disclosed material changes
--------------------------------------------------------------------------------

- Company made an updated corporate presentation available on its website on November 12, 2024.
- Presentation furnished as Exhibit 99.1; no specific financial or operational updates detailed in the filing.
- No new financial guidance, clinical data, or corporate developments disclosed in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/0001193125-24-255170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/d794017d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-255170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer